Vitrafy Life Sciences Ltd
VFY
Company Profile
Business description
Vitrafy Life Sciences Ltd developed a range of proprietary smart cryopreservation hardware devices and Lifechain, an integrated, cloud-based software platform, to provide a complete, vertically integrated cryopreservation solution to retain the quality of cryopreserved biomaterials. The company devices includes Vitrafy’s Smart Cryopreservation Device; Vitrafy’s Smart Thawing Device and Vitrafy’s Smart Packaging.
Contact
385 Bourke Street
Suite 2, Level 11
MelbourneVIC3000
AUST: +61 396927222
Sector
Technology
Stock type
Sensitive
Industry
Software - Infrastructure
Fiscal Year End
30 June 2027
Employees
Stocks News & Analysis
stocks
What did Morningstar subscribers buy and sell during June?
ETFs took centre stage in June alongside renewed interest in beaten down growth names.
stocks
Australia’s largest gold miner downgraded on a falling gold price
A cooling gold price sees fair value cuts across the board.
stocks
Cheap ASX share pays a heavy price for NRL rights
Growth has slowed amid increased competition for viewers and content.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,964.30 | 33.30 | -0.37% |
| CAC 40 | 8,364.65 | 25.69 | 0.31% |
| DAX 40 | 25,114.25 | 47.16 | 0.19% |
| Dow JONES (US) | 52,498.64 | 138.37 | -0.26% |
| FTSE 100 | 10,498.29 | 1.00 | 0.01% |
| HKSE | 24,162.92 | 50.80 | -0.21% |
| NASDAQ | 25,873.18 | 408.43 | -1.55% |
| Nikkei 225 | 66,678.36 | 564.37 | -0.84% |
| NZX 50 Index | 13,612.33 | 110.87 | -0.81% |
| S&P 500 | 7,515.34 | 60.05 | -0.79% |
| S&P/ASX 200 | 8,772.70 | 31.00 | -0.35% |
| SSE Composite Index | 3,905.88 | 7.91 | -0.20% |